Tag: Pankaj R Patel
Zydus gets go ahead for phase-2 clinical trial of its novel...
The company will soon begin the Phase II (a) clinical trial of ZYIL1, a novel oral NLRP3 inflammasome inhibitor in patients with Cryopyrin-Associated Periodic Syndrome (CAPS), a rare life-long auto-inflammatory condition in Australia
Zydus’ Desidustat shows efficacy & safety in treating Hypoxia in hospitalized...
Novel mechanism of targeting ‘hypoxia’ through HIF-PH inhibitor was studied for the first time in Hospitalised Covid-19 Patients in Mexico. Study trial indicates that the use of Desidustat for 14 days reduced CRP between baseline and day 14 among hospitalised patients with COVID-19.........................
Zydus to begin Phase I trials of its inflammation drug, ZYIL1
Phase I trial will study the safety, tolerability, pharmacokinetics and pharmacodynamics of ZYIL1 in healthy human volunteers. Zydus has secured a Strong IP portfolio with multiple patents filed in all major countries.....................